258 related articles for article (PubMed ID: 32101579)
1. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials.
Hengartner MP; Jakobsen JC; Sørensen A; Plöderl M
PLoS One; 2020; 15(2):e0229381. PubMed ID: 32101579
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
Heo M; Murphy CF; Meyers BS
Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
[TBL] [Abstract][Full Text] [Related]
3. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.
Khan A; Khan SR; Shankles EB; Polissar NL
Int Clin Psychopharmacol; 2002 Nov; 17(6):281-5. PubMed ID: 12409681
[TBL] [Abstract][Full Text] [Related]
4. Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression.
Hengartner MP; Plöderl M
BMJ Evid Based Med; 2022 Apr; 27(2):69-73. PubMed ID: 33593736
[TBL] [Abstract][Full Text] [Related]
5. Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.
Hudgens S; Floden L; Blackowicz M; Jamieson C; Popova V; Fedgchin M; Drevets WC; Cooper K; Lane R; Singh J
J Affect Disord; 2021 Feb; 281():767-775. PubMed ID: 33261932
[TBL] [Abstract][Full Text] [Related]
6. A factor analytic study in bipolar depression, and response to lamotrigine.
Mitchell PB; Hadzi-Pavlovic D; Evoniuk G; Calabrese JR; Bowden CL
CNS Spectr; 2013 Aug; 18(4):214-24. PubMed ID: 23702258
[TBL] [Abstract][Full Text] [Related]
7. Relative sensitivity of the Montgomery-Asberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis.
Khan A; Brodhead AE; Kolts RL
Int Clin Psychopharmacol; 2004 May; 19(3):157-60. PubMed ID: 15107658
[TBL] [Abstract][Full Text] [Related]
8. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
Zimmerman M; Posternak MA; Chelminski I
J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
[TBL] [Abstract][Full Text] [Related]
9. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a standardised saffron extract (affron®) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study.
Lopresti AL; Smith SJ; Hood SD; Drummond PD
J Psychopharmacol; 2019 Nov; 33(11):1415-1427. PubMed ID: 31475623
[TBL] [Abstract][Full Text] [Related]
12. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants for depression in patients with dementia: a review of the literature.
Leong C
Consult Pharm; 2014 Apr; 29(4):254-63. PubMed ID: 24704894
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
[TBL] [Abstract][Full Text] [Related]
15. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores.
Ruhé HG; Dekker JJ; Peen J; Holman R; de Jonghe F
Compr Psychiatry; 2005; 46(6):417-27. PubMed ID: 16275208
[TBL] [Abstract][Full Text] [Related]
17. The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
Fantino B; Moore N
BMC Psychiatry; 2009 May; 9():26. PubMed ID: 19473506
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant.
Floden L; Hudgens S; Jamieson C; Popova V; Drevets WC; Cooper K; Singh J
CNS Drugs; 2022 Jun; 36(6):649-658. PubMed ID: 35441931
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
20. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
Nelson JC; Delucchi K; Schneider LS
Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
